Soon, a new treatment will be available to help people with type 2 diabetes. Invokana, released by Johnson & Johnson, attacks blood sugar helps reduce the amount of sugar absorbed into the bloodstream.
Reducing this means that the body will flush out the excess sugar through the urine. According to an article released by Forbes, doctors are excited about the drug because it lowers blood sugar differently than any other diabetes drug on the market today.
So far Johnson & Johnson has documented clinical trials involving more than 10,000 patients. The main side effects reported included urinary tract and yeast infections.